Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-54.68%
operating margin TTM
-60.09%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -35.73 |
| peg ratio | -1.23 |
| price to book ratio | 14.47 |
| price to sales ratio | 19.61 |
| enterprise value multiple | -38.15 |
| price fair value | 14.47 |
profitability ratios | |
|---|---|
| gross profit margin | 96.01% |
| operating profit margin | -60.09% |
| pretax profit margin | -54.68% |
| net profit margin | -54.68% |
| return on assets | -27.76% |
| return on equity | -38.38% |
| return on capital employed | -37.83% |
liquidity ratios | |
|---|---|
| current ratio | 5.11 |
| quick ratio | 4.78 |
| cash ratio | 0.97 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,125.51 |
| operating cycle | 1,181.60 |
| days of payables outstanding | 673.12 |
| cash conversion cycle | 508.48 |
| receivables turnover | 6.51 |
| payables turnover | 0.54 |
| inventory turnover | 0.32 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.12 |
| debt equity ratio | 0.18 |
| long term debt to capitalization | 0.15 |
| total debt to capitalization | 0.15 |
| interest coverage | -22.55 |
| cash flow to debt ratio | -2.48 |
cash flow ratios | |
|---|---|
| free cash flow per share | -13.89 |
| cash per share | 36.12 |
| operating cash flow per share | -13.84 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -2.48 |
| short term coverage ratios | -293.05 |
| capital expenditure coverage ratio | -315.62 |
Frequently Asked Questions
When was the last time Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reported earnings?
Madrigal Pharmaceuticals, Inc. (MDGL) published its most recent earnings results on 05-08-2025.
What is Madrigal Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)'s trailing twelve months ROE is -38.38%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Madrigal Pharmaceuticals, Inc. (MDGL) currently has a ROA of -27.76%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MDGL's net profit margin stand at?
MDGL reported a profit margin of -54.68% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MDGL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.11 in the most recent quarter. The quick ratio stood at 4.78, with a Debt/Eq ratio of 0.18.